Zuellig Pharma Acquires Cialis® (Tadalafil) from Lilly in SingaporeMedia Outreach|03/08/202604/08/2026oleh RRINEWSSSINGAPORE – Media OutReach Newswire – 3 August 2026 – Zuellig Pharma, a leading
Zuellig Pharma Reinforces Commitment to Japan through Its New Misato Depot, Advancing Clinical Logistics and Sourcing ExcellenceMedia Outreach|26/03/2026oleh RRINEWSSMISATO, JAPAN – Media OutReach Newswire – 26 March 2026 – Zuellig Pharma today
Zuellig Pharma Acquires Cialis® (Tadalafil) from Lilly in three additional markets in AsiaMedia Outreach|12/03/2026oleh RRINEWSSSINGAPORE – Media OutReach Newswire – 12 March 2026 – Zuellig Pharma, a leading
Zuellig Pharma Strengthens Consumer Healthcare Portfolio with the Acquisition of Zam-Buk® and Vapex® Brands from BayerMedia Outreach|09/02/2026oleh RRINEWSSSINGAPORE – Media OutReach Newswire – 9 February 2026 – Zuellig Pharma, a leading
Zuellig Pharma expands partnership with Lundbeck to support commercialization of neuro-psychiatric health solutions in AsiaMedia Outreach|16/12/2025oleh RRINEWSSSINGAPORE – Media OutReach Newswire – 16 December 2025 – Zuellig Pharma, a leading healthcare
Zuellig Pharma unveils state-of-the-art Clinical Trial Support Innovation Center in South Korea to support both domestic and global clinical research needsMedia Outreach|01/12/2025oleh RRINEWSSNew facility is set to be South Korea’s most advanced automated hub
Zuellig Pharma Launches Lilly’s Innovative Obesity and Diabetes Medicine in ThailandMedia Outreach|27/05/202527/05/2025oleh RRINEWSSMounjaro® (tirzepatide) will be available in the market from the end of
